# FS KKR Capital Corp: financial statements, quarterly

FSK · NYSE · CIK 1422183 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fsk.md) · [Financials](/companies/fsk/financials.md) · [Filings](/companies/fsk/filings.md) · [Insiders](/companies/fsk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fsk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [117](/filings/0001628280-23-037067.md) | [118 d](/filings/0001628280-25-008175.md) | [116](/filings/0001628280-24-021724.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [265](/filings/0001628280-25-008175.md) | [90.0](/filings/0001628280-25-008175.md) | [173](/filings/0001628280-26-011734.md) | [105](/filings/0001628280-26-011734.md) | [160](/filings/0001628280-26-011734.md) | [147](/filings/0001628280-26-011734.md) | [120](/filings/0001628280-26-033118.md) | [(209)](/filings/0001628280-26-053783.md) | [214](/filings/0001628280-26-011734.md) | [(114)](/filings/0001628280-26-011734.md) | [(441)](/filings/0001628280-26-033118.md) | [(34.0)](/filings/0001628280-26-053783.md) |
| Diluted EPS | $ per share | [0.95](/filings/0001628280-25-008175.md) | [0.32](/filings/0001628280-25-008175.md) | [0.62](/filings/0001628280-26-011734.md) | [0.37](/filings/0001628280-26-011734.md) | [0.57](/filings/0001628280-26-011734.md) | [0.52](/filings/0001628280-26-011734.md) | [0.43](/filings/0001628280-26-033118.md) | [(0.75)](/filings/0001628280-26-053783.md) | [0.76](/filings/0001628280-26-011734.md) | [(0.41)](/filings/0001628280-26-011734.md) | [(1.57)](/filings/0001628280-26-033118.md) | [(0.13)](/filings/0001628280-26-053783.md) |
| Basic EPS | $ per share | [0.95](/filings/0001628280-25-008175.md) | [0.32](/filings/0001628280-25-008175.md) | [0.62](/filings/0001628280-26-011734.md) | [0.37](/filings/0001628280-26-011734.md) | [0.57](/filings/0001628280-26-011734.md) | [0.52](/filings/0001628280-26-011734.md) | [0.43](/filings/0001628280-26-033118.md) | [(0.75)](/filings/0001628280-26-053783.md) | [0.76](/filings/0001628280-26-011734.md) | [(0.41)](/filings/0001628280-26-011734.md) | [(1.57)](/filings/0001628280-26-033118.md) | [(0.13)](/filings/0001628280-26-053783.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [15.4](/filings/0001628280-23-037067.md) | [15.5](/filings/0001628280-25-008175.md) | [15.2](/filings/0001628280-24-021724.md) | [15.1](/filings/0001628280-24-035234.md) | [15.1](/filings/0001628280-24-045744.md) | [14.2](/filings/0001628280-26-011734.md) | [14.9](/filings/0001628280-25-023202.md) | [14.6](/filings/0001628280-25-038368.md) | [13.9](/filings/0001628280-25-049617.md) | [13.7](/filings/0001628280-26-053783.md) | [12.8](/filings/0001628280-26-033118.md) | [12.0](/filings/0001628280-26-053783.md) |
| Total liabilities | $bn | [8.4](/filings/0001628280-23-037067.md) | [8.6](/filings/0001628280-25-008175.md) | [8.3](/filings/0001628280-24-021724.md) | [8.4](/filings/0001628280-24-035234.md) | [8.5](/filings/0001628280-24-045744.md) | [7.6](/filings/0001628280-26-011734.md) | [8.4](/filings/0001628280-25-023202.md) | [8.5](/filings/0001628280-25-038368.md) | [7.8](/filings/0001628280-25-049617.md) | [7.9](/filings/0001628280-26-053783.md) | [7.6](/filings/0001628280-26-033118.md) | [6.7](/filings/0001628280-26-053783.md) |
| Long-term debt | $bn | [8.0](/filings/0001628280-23-037067.md) | [8.2](/filings/0001628280-25-008175.md) | [7.9](/filings/0001628280-24-021724.md) | [8.0](/filings/0001628280-24-035234.md) | [8.1](/filings/0001628280-24-045744.md) | [7.4](/filings/0001628280-26-011734.md) | [8.0](/filings/0001628280-25-023202.md) | [8.0](/filings/0001628280-25-038368.md) | [7.4](/filings/0001628280-25-049617.md) | [7.6](/filings/0001628280-26-053783.md) | [7.3](/filings/0001628280-26-033118.md) | [6.5](/filings/0001628280-26-053783.md) |
| Shareholders' equity | $bn | [7.0](/filings/0001628280-24-045744.md) | [6.8](/filings/0001628280-26-011734.md) | [6.8](/filings/0001628280-25-038368.md) | [6.7](/filings/0001628280-25-049617.md) | [6.7](/filings/0001628280-25-049617.md) | [6.6](/filings/0001628280-26-053783.md) | [6.5](/filings/0001628280-26-053783.md) | [6.1](/filings/0001628280-26-053783.md) | [6.2](/filings/0001628280-25-049617.md) | [5.8](/filings/0001628280-26-053783.md) | [5.3](/filings/0001628280-26-053783.md) | [5.1](/filings/0001628280-26-053783.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [242 d](/filings/0001628280-24-045744.md) | [134 d](/filings/0001628280-26-011734.md) | [466](/filings/0001628280-25-023202.md) | [376 d](/filings/0001628280-25-038368.md) | [81.0 d](/filings/0001628280-25-049617.md) | [978 d](/filings/0001628280-26-011734.md) | [(418)](/filings/0001628280-26-033118.md) | [108 d](/filings/0001628280-26-053783.md) | [707 d](/filings/0001628280-25-049617.md) | [195 d](/filings/0001628280-26-011734.md) | [245](/filings/0001628280-26-033118.md) | [776 d](/filings/0001628280-26-053783.md) |
| Dividends paid | $m | [210 d](/filings/0001628280-24-045744.md) | [211 d](/filings/0001628280-26-011734.md) | [210](/filings/0001628280-25-023202.md) | [210 d](/filings/0001628280-25-038368.md) | [196 d](/filings/0001628280-25-049617.md) | [392 d](/filings/0001628280-26-011734.md) | [0.0](/filings/0001628280-26-033118.md) | [196 d](/filings/0001628280-26-053783.md) | [196 d](/filings/0001628280-25-049617.md) | [392 d](/filings/0001628280-26-011734.md) | [0.0](/filings/0001628280-26-033118.md) | [134 d](/filings/0001628280-26-053783.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-045744.md) | [0.0 d](/filings/0001628280-26-011734.md) | [0.0](/filings/0001628280-24-021724.md) | [0.0 d](/filings/0001628280-24-035234.md) | [0.0 d](/filings/0001628280-24-045744.md) | [0.0 d](/filings/0001628280-26-011734.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [280](/filings/0001628280-25-008175.md) | [280](/filings/0001628280-25-008175.md) | [280](/filings/0001628280-26-011734.md) | [280](/filings/0001628280-26-011734.md) | [280](/filings/0001628280-26-011734.md) | [280](/filings/0001628280-26-011734.md) | [280](/filings/0001628280-26-033118.md) | [280](/filings/0001628280-26-053783.md) | [280](/filings/0001628280-26-011734.md) | [280](/filings/0001628280-26-011734.md) | [280](/filings/0001628280-26-033118.md) | [280](/filings/0001628280-26-053783.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 276,340,280 at 2026-08-05, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053783.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.